Zoetis (NYSE:ZTS) Declares $0.432 Dividend and Unveils Innovative Vetscan OptiCell for Market Growth
Zoetis is launching the AI-powered Vetscan OptiCell™ to improve veterinary care efficiency and has declared a stable dividend. Despite challenges like a slight profit margin dip and high debt levels, the company's strong financial health and market positioning suggest potential undervaluation.